Related Experiment Video
Updated: Jul 27, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Cardiovascular involvement in Epstein-Barr virus infection
Xinying Chen1, Yingying Li2, Lijun Deng1,2
1Department of Pediatrics, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Cardiovascular complications from Epstein-Barr virus (EBV) infection, including coronary artery issues and myocarditis, are severe but rare. Prompt diagnosis and treatment are crucial for better outcomes in EBV-related heart damage.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Epstein-Barr virus (EBV) infection can lead to uncommon but severe cardiovascular complications.
- These complications, including coronary artery dilation (CAD) and myocarditis, have a poor prognosis if not managed promptly.
- Current understanding and clinical guidance for EBV-associated cardiovascular damage are limited.
Purpose of the Study:
- To synthesize current knowledge on cardiovascular damage associated with EBV infection.
- To provide an overview of the pathogenesis, classification, treatment, and prognosis of these complications.
- To enhance clinical recognition and management of EBV-related cardiovascular issues.
Main Methods:
- Review of existing literature on cardiovascular manifestations of Epstein-Barr virus infection.
- Synthesis of data regarding pathogenesis, clinical presentation, and diagnostic approaches.
- Compilation of current treatment strategies and prognostic factors.
Main Results:
- Cardiovascular involvement in EBV infection presents diverse manifestations like CAD, coronary artery aneurysm (CAA), myocarditis, arrhythmias, and heart failure.
- Untreated cardiovascular damage can progress, leading to significant mortality.
- There is a need for more large-scale data and evidence-based guidelines for effective management.
Conclusions:
- Cardiovascular complications of EBV infection require increased clinical attention due to their severity and potential for poor outcomes.
- Early diagnosis and intervention are key to improving prognosis and reducing mortality.
- This review aims to support clinicians in recognizing and managing these challenging cases.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis IV: Nursing Management